Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Association between Native Myocardial T1 Mapping and Cardiac Function and Macroscopic Fibrosis in Thalassemia Major

Alessia Pepe, MD PhD, Nicola Martini, Antonio De Luca, Vincenzo Positano, Laura Pistoia, PhD, Giovan Battista Ruffo, Marilena Serra, MD, Calogera Gerardi, MD, Monica Benni, Crocetta Argento, Aurelio Maggio, MD, Gianfranco Sinagra, Antonella Meloni, PhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-134585

Published: 2020

Journal Articles

LIC-R2 Values Predict Severity of SCD: Baseline Data from Licnet-S

Rosario Di Maggio, MD, Angela Vitrano, PhD, Carmelo Fidone, MD, Alessandra Quota, MD, Daniela Fiorino, MD, Calogera Gerardi, MD, Saveria Campisi, MD, Lorenzo Tesé, MD, Vincenzo Santoro, MD, Barone Rita, MD, Giangreco Antonino, MD, Paolo Rigano, Lorella Pitrolo, MD, Aurelio Maggio, MD

Blood (2019) 134 (Supplement_1): 4810.

https://doi.org/10.1182/blood-2019-124728

Published: 2019

Journal Articles

Correlation between Changes in Cardiac Iron and Hepatic Iron in Pediatric Patients with Thalassemia Major

Alessia Pepe, MD, Antonella Meloni, PhD, Aldo Filosa, Laura Pistoia, Tommaso Casini, Roberto Lisi, Maria Caterina Putti, MD, Aurelio Maggio, MD, Calogera Gerardi, MD, Priscilla Fina, Vincenzo Positano, Maddalena Casale, MD

Blood (2019) 134 (Supplement_1): 2241.

https://doi.org/10.1182/blood-2019-121730

Published: 2019

Journal Articles

Multicenter Validation of the Magnetic Resonance T2* Technique for Quantification of Pancreatic Iron

Alessia Pepe, MD, Laura Pistoia, Daniele De Marchi, Stefano Pulini, MD, Elena Facchini, MD, Nicola Dello Iacono, Aurelio Maggio, MD, Maria Grazia Bisconte, MD, Maria Paola Smacchia, Calogera Gerardi, MD, Nicolò Schicchi, Gennaro Restaino, Vincenzo Positano, Antonella Meloni, PhD

Blood (2018) 132 (Supplement 1): 3637.

https://doi.org/10.1182/blood-2018-99-110161

Published: 2018

Journal Articles

Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies

Angela Vitrano, PhD, Massimiliano Sacco, DR, Rosamaria Rosso, MD, Alessandra Quota, MD, Daniela Fiorino, MD, Esther Natalie Oliva, MD, Calogera Gerardi, MD, Gaetano Roccamo, MD, Vincenzo Spadola, MD, Aldo Filosa, MD, Lorenzo Tesé, MD, Giuseppina Calvaruso, MD, Lorella Pitrolo, MD, Laura Mistretta, DR, Filippo Cassarà, DR, Rosario Di Maggio, MD, Aurelio Maggio, MD

Blood (2017) 130 (Supplement 1): 936.

https://doi.org/10.1182/blood.V130.Suppl_1.936.936

Published: 2017

Journal Articles

Pancreatic Iron and Bone Health in Thalassemia Major

Antonella Meloni, PhD, Silvia Maffei, Laura Pistoia, MD, Cristina Vassalle, Maria Caterina Putti, MD, Angelo Peluso, MD, Calogera Gerardi, MD, Cristina Paci, Elena Facchini, Maria Grazia Sanna, Aurelio Maggio, MD, Vincenzo Positano, Alessia Pepe, MD

Blood (2017) 130 (Supplement 1): 4765.

https://doi.org/10.1182/blood.V130.Suppl_1.4765.4765

Published: 2017

Journal Articles

Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia

Blood (2015) 126 (23): 2141.

https://doi.org/10.1182/blood.V126.23.2141.2141

Published: 2015

Journal Articles

Different Thresholds of Serum Ferritin Levels for Prediction of Liver Iron Concentration in Hemoglobinopathies

Blood (2015) 126 (23): 2146.

https://doi.org/10.1182/blood.V126.23.2146.2146

Published: 2015

Journal Articles

Hematopoietic Peripheral Circulating Blood Stem Cells As an Independent Marker of Good Transfusion Management in Patients with Beta-Thalassemia

Mariasanta Napolitano, MDPhD, Calogera Gerardi, MD, Anna Di Lucia, MD, Pietro Andrea Accardo, MD, Luigi Rizzuto, PhD, Ferraro Maria, PhD, Giuseppe Tarantino, MD, Sergio Siragusa, MD, Filippo Buscemi, MD

Blood (2015) 126 (23): 957.

https://doi.org/10.1182/blood.V126.23.957.957

Published: 2015

Journal Articles

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Blood (2014) 124 (21): 1354.

https://doi.org/10.1182/blood.V124.21.1354.1354

Published: 2014

Journal Articles

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Blood (2011) 118 (21): 3197.

https://doi.org/10.1182/blood.V118.21.3197.3197

Published: 2011

Journal Articles

Left Ventricular Volumes, Mass and Function Normalized to the Body Surface Area, Age and Gender From CMR in a Large Cohort of Well-Treated Thalassemia Major Patients without Myocardial Iron Overload

Antonella Meloni, PhD, Giovanni Aquaro, Pierluigi Festa, Francesco Gagliardotto, Angelo Zuccarelli, Calogera Gerardi, M.D., Michele Santodirocco, Maria Antonietta Romeo, M.D., Maria Rita Gamberini, Maria Paola Smacchia, Giovanni Palazzi, Elisabetta Chiodi, Lucia De Franceschi, MD, Vincenzo Positano, Massimo Lombardi, Alessia Pepe

Blood (2011) 118 (21): 1090.

https://doi.org/10.1182/blood.V118.21.1090.1090

Published: 2011

Journal Articles

Feasibility, Reproducibility and Reliability for the T2* Iron Evaluation At 3T in Comparison with 1.5T

Antonella Meloni, PhD, Vincenzo Positano, Petra Keilberg, Daniele De Marchi, Pasquale Pepe, Angelo Zuccarelli, Saveria Campisi, Maria Antonietta Romeo, M.D., Tommaso Casini, Pier Paolo Bitti, Calogera Gerardi, M.D., Maria Eliana Lai, Basilia Piraino, Gaetano Giuffrida, Giuseppina Secchi, Lucia De Franceschi, MD, Massimo Midiri, Massimo Lombardi, Alessia Pepe

Blood (2011) 118 (21): 5301.

https://doi.org/10.1182/blood.V118.21.5301.5301

Published: 2011

Journal Articles

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Blood (2011) 118 (21): 5302.

https://doi.org/10.1182/blood.V118.21.5302.5302

Published: 2011

Journal Articles

Comparison of Deferasirox, Deferiprone, and Desferrioxamine Effectiveness on Myocardial Iron Concentrations and Biventricular Function by Quantitative MR in Beta-Thalassemia Major

Blood (2008) 112 (11): 3872.

https://doi.org/10.1182/blood.V112.11.3872.3872

Published: 2008

Journal Articles

Decrease of Mortality during Deferiprone Treatments: Results from A Large Randomised Cohort of Thalassemia Major Patients Under the Auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Blood (2008) 112 (11): 3885.

https://doi.org/10.1182/blood.V112.11.3885.3885

Published: 2008

Journal Articles

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

Blood (2007) 110 (11): 575.

https://doi.org/10.1182/blood.V110.11.575.575

Published: 2007

NARROW

Association between Native Myocardial T1 Mapping and Cardiac Function and Macroscopic Fibrosis in Thalassemia Major

LIC-R2 Values Predict Severity of SCD: Baseline Data from Licnet-S

Correlation between Changes in Cardiac Iron and Hepatic Iron in Pediatric Patients with Thalassemia Major

Multicenter Validation of the Magnetic Resonance T2* Technique for Quantification of Pancreatic Iron

Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies

Pancreatic Iron and Bone Health in Thalassemia Major

Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia

Different Thresholds of Serum Ferritin Levels for Prediction of Liver Iron Concentration in Hemoglobinopathies

Hematopoietic Peripheral Circulating Blood Stem Cells As an Independent Marker of Good Transfusion Management in Patients with Beta-Thalassemia

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Left Ventricular Volumes, Mass and Function Normalized to the Body Surface Area, Age and Gender From CMR in a Large Cohort of Well-Treated Thalassemia Major Patients without Myocardial Iron Overload

Feasibility, Reproducibility and Reliability for the T2* Iron Evaluation At 3T in Comparison with 1.5T

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Comparison of Deferasirox, Deferiprone, and Desferrioxamine Effectiveness on Myocardial Iron Concentrations and Biventricular Function by Quantitative MR in Beta-Thalassemia Major

Decrease of Mortality during Deferiprone Treatments: Results from A Large Randomised Cohort of Thalassemia Major Patients Under the Auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only